Dr. Hicks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1720 Nicholasville Road
Suite 701
Lexington, KY 40503Phone+1 859-276-0414Fax+1 859-276-3765
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1991 - 1994
Indiana University School of MedicineResidency, Internal Medicine, 1988 - 1991
University of Louisville School of MedicineClass of 1988
Certifications & Licensure
KY State Medical License 1994 - 2025
OH State Medical License 1991 - 1994- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsA multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxe...Hani M. Babiker, Peter J. Schlegel, Lee G. Hicks, Andrea J. Bullock, Nafisa Burhani
Investigational New Drugs. 2021-08-21 - 12 citationsA phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC).Tanios Bekaii-Saab, Amir Mortazavi, Lee G. Hicks, Mark M. Zalupski, Robert Pelley
Investigational New Drugs. 2006-01-28 - 1 citationsGM-CSF Did Not Allow Doxorubicin Dose Escalation in the MAID Regimen: A Phase I Trial. A Southwest Oncology Group StudyLee G. Hicks, Stanley P. Balcerzak, Mark M. Zalupski
Cancer Investigation. 1996-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
